Semaglutide is generally well tolerated with very similar dropout costs when compared with placebo, even though it can be less properly tolerated than dulaglutide (Trulicity).one,3 The most common adverse outcomes are nausea, vomiting, and diarrhea and will be seasoned by about 30% of sufferers, ord